US Gilead hopes cut-price pan-genomic hep C combo will revive s... Epclusa is first treatment for all six major virus genotypes.
News FDA panel narrowly backs heart benefit of BI/Lilly diabetes ... FDA advisers voted 12-11 that Jardiance also reduces cardiovascular risks.
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
Views & Analysis The FDA's role in the digital health monitoring space How can pharma read signals coming from clinical trials to predict FDA judgements on digital health products?
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
News BridgeBio gains on phase 3 dwarfism data Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
